83
Sacheli R, Delacroix L, Vandenackerveken P,
NguyenL,MalgrangeB.Gene transfer in innerear
cells: achallenging race. GeneTher 2013;20:237-
47.
Sartelet A, Stauber T, Coppieters W, Ludwig CF,
Fasquelle C, Druet T, Zhang Z, Ahariz N, Cambi-
sanoN, JentschTJ, CharlierC.Amissensemuta-
tionaccelerating thegatingof the lysosomal Cl-/
H+-exchanger ClC-7/Ostm1 causes osteopetro-
siswithgingival hamartomas incattle. DisModel
Mech2013;7:119-28.
Schoenen J, JensenRH, Lanteri-MinetM, Lainez
MJ, Gaul C, GoodmanAM, CaparsoA,MayA. Sti-
mulation of the sphenopalatine ganglion (SPG)
for cluster headache treatment. PathwayCH-1: A
randomized, sham-controlled study. Cephalalgia
2013;33:816-30.
Schoenen J, Vandersmissen B, Jeangette S,
Herroelen L, VandenheedeM, Gerard P, Magis D.
Migraine preventionwith a supraorbital transcu-
taneousstimulator: A randomizedcontrolled trial.
Neurology2013;80:697-704.
Seredynski AL, Balthazart J, Christophe VJ, Ball
GF, Cornil CA. Neuroestrogens rapidly regulate
sexual motivation but not performance. J Neu-
rosci 2013;33:164-74.
Somja J, Demoulin S, Roncarati P, Herfs M, Ble-
tard N, Delvenne P, Hubert P. Dendritic Cells in
Barrett’s Esophagus Carcinogenesis: An Inade-
quate Microenvironment for Antitumor Immu-
nity?AmJPathol 2013;182:2168-79.
Sounni NE, Noel A. Targeting the tumor mi-
croenvironment for cancer therapy. Clin Chem
2013;59:85-93.
Tabruyn SP, Hansen S, Ojeda-Fernandez ML,
Bovy N, Zarrabeitia R, Recio-Poveda L, Berna-
beu C, Martial JA, Botella LM, Struman I. MiR-
205 is downregulated in hereditary hemor-
rhagic telangiectasia and impairs TGF-beta
signaling pathways in endothelial cells. Angioge-
nesis2013;16:877-87.
Toussaint M, Fievez L, Drion PV, Cataldo D, Bu-
reauF, LekeuxP, Desmet CJ.Myeloidhypoxia-in-
ducible factor 1alpha prevents airway allergy in
mice throughmacrophage-mediated immunore-
gulation.Mucosal Immunol 2013;6:485-97.
TurtoiA,BlommeA,BellahceneA,GillesC,Henne-
quiere V, PeixotoP, Bianchi E, Noël A, De Pauw E,
LifrangeE, DelvenneP, CastronovoV.Myoferlin is
a key regulator of EGFR activity in breast cancer.
CancerRes2013;73:5438-48.
Vandenbosch R, Chocholova E, Robe PA, Wang
Y, Lambert C,MoonenG, LallemendF,Malgrange
B, HadjabS. A role for the canonical nuclear fac-
tor-kBpathway incouplingneurotrophin-induced
differential survival of developing spiral ganglion
neurons. Front Cell Neurosci 2013;7.
Vandermeers F, Neelature Sriramareddy S, Costa
C, Hubaux R, Cosse JP, Willems L. The role of
epigenetics in malignant pleural mesothelioma.
LungCancer 2013;81:311-8.
VanderzwalmenP, ConnanD, Grobet L, Wirleitner
B, Remy B, VanderzwalmenS, ZechN, Ectors FJ.
Lower intracellular concentration of cryoprotec-
tants after vitrification than after slow freezing
despiteexposure tohigher concentrationof cryo-
protectant solutions.HumReprod2013;28:2101-
10.
Vignisse J, SteinbuschHW, Grigoriev V, Bolkunov
A, ProshinA, BettendorffL, BachurinS, Strekalova
T. Concomitant manipulation of murine NMDA-
and AMPA-receptors to produce pro-cognitive
drugeffects inmice. EurNeuropsychopharmacol
2014;24:309-20.
Wild JM, Balthazart J. Neural pathways media-
ting control of reproductive behavior inmale Ja-
panesequail. JCompNeurol 2013;521:2067-87.
OTHERPUBLICATIONS
GIGAmembers inbold
Alward BA,
Balthazart J
, Ball GF. Differential ef-
fects of global versus local testosterone on sin-
gingbehavior and itsunderlyingneural substrate.
PNatl AcadSci USA2013;110:19573-8.
AndrusiakMG,
VandenboschR
, DickFA, ParkDS,
Slack RS. LXCXE-independent chromatin remo-
deling by Rb/E2f mediates neuronal quiescence.
Cell Cycle2013;12:1416-23.
AnttilaV,WinsvoldBS, GormleyP, KurthT, Bettella
F, McMahonG, KallelaM, MalikR, deVriesB, Te-
rwindtG,MedlandSE, TodtU,McArdleWL, Quaye
L, KoiranenM, IkramMA, Lehtimaki T, Stam AH,
LigthartL,WedenojaJ,Dunham I,NealeBM,Palta
P, HamalainenE, SchurksM, Rose LM, BuringJE,
RidkerPM, SteinbergS, StefanssonH, Jakobsson
F, LawlorDA, EvansDM,RingSM, FarkkilaM,Artto
V, KaunistoMA, Freilinger T,
Schoenen J,
Frants
RR, Pelzer N, Weller CM, Zielman R, Heath AC,
Madden PA, Montgomery GW, Martin NG, Borck
G,GobelH,HeinzeA,Heinze-KuhnK,WilliamsFM,
Hartikainen AL, Pouta A, van den Ende J, Uitter-
linden AG, Hofman A, AminN, Hottenga JJ, Vink
JM, Heikkila K, Alexander M, Muller-Myhsok B,
Schreiber S, Meitinger T, Wichmann HE, Aromaa
A, Eriksson JG, Traynor BJ, Trabzuni D, Rossin E,
Lage K, Jacobs SB, Gibbs JR, Birney E, Kaprio J,
Penninx BW, BoomsmaDI, vanDuijnC, Raitakari
O, JarvelinMR, Zwart JA, CherkasL, StrachanDP,
KubischC, FerrariMD, vandenMaagdenbergAM,
DichgansM, WessmanM, SmithGD, Stefansson
K,DalyMJ,NyholtDR, ChasmanDI, PalotieA.Ge-
nome-widemeta-analysis identifiesnewsuscep-
tibility loci formigraine.NatGenet2013;45:912-7.
Avila A,
Nguyen L
, Rigo JM. Glycine receptors
and brain development. Front Cell Neurosci
2013;7:184.
Bambi-Nyanguile SM,
Hanson J,
Ooms A, Alpan
L, Kolh P, Dogne JM, Pirotte B. Synthesis and
pharmacological evaluation of 2-aryloxy/aryla-
mino-5-cyanobenzenesulfonylureas as novel
thromboxane A(2) receptor antagonists. Eur J
MedChem2013;65:32-40.
BarnetteDN,HulinA, AhmedAS,
ColigeAC
, Azhar
M, Lincoln J. Tgfbeta-Smad andMAPK signaling
mediatescleraxisandproteoglycanexpression in
heart valves. JMol Cell Cardiol 2013;65:137-46.
Berry S,
Coppieters W
, Davis S, Burrett A, Tho-
mas N, Palmer D, Kelly V, Obolonkin V, Sanders
K, Spelman R,
Georges M
, Lehnert K, Snell R. A
triadofhighlydivergentpolymeric immunoglobu-
lin receptor (PIGR) haplotypes with major effect
on IgA concentration in bovine milk. PLoS One
2013;8:e57219.
BjerkSM, BakerJV, EmeryS,NeuhausJ, AngusB,
GordinFM, Pett SL, StephanC, Kunisaki KM. Bio-
markersandbacterial pneumonia risk inpatients
with treated HIV infection: a case-control study.
PLoSOne2013;8:e56249.
Bonanni P, Gershon A, Gershon M, Kulcsar A,
Papaevangelou V,
Rentier B, Sadzot-Delvaux
C
, Usonis V, Vesikari T, Weil-Olivier C, de Win-
ter P, Wutzler P. Primary Versus Secondary Fai-
lure After Varicella Vaccination: Implications for
Interval Between 2 Doses. Pediatr Infect Dis J
2013;32:e305-e313.
Cahn P, Pozniak AL, Mingrone H, Shuldyakov A,
Brites C, Andrade-Villanueva JF, Richmond G,
Buendia CB, Fourie J, Ramgopal M, Hagins D,
FelizartaF,MadrugaJ,ReuterT,NewmanT, Small
CB, Lombaard J, Grinsztejn B, Dorey D, Unde-
rwood M, Griffith S, Min S. Dolutegravir versus
raltegravir in antiretroviral-experienced, inte-
